Clinical trial Recruiting at 1 site Observational Ages 18 to 80

Exploring the link between cancer and blood clots

Official title: The Correlation Between Circulatory Tumor Cells and Venous Thrombosis

Run by Chang Gung Memorial Hospital · NCT06672250 · Data updated 2026-11-12

This study is trying to see how cancer cells in the blood might be linked to blood clots in cancer patients and whether treatments like aspirin can help.

Quick facts

Study typeObservational
Ages18 Years to 80 Years
SexAll
Enrollment120 (estimated)
SponsorChang Gung Memorial Hospital
Academic / other
Drugs / interventionschemotherapy
Locations1 site (New Taipei City)
StatusRecruiting
StartedMay 28, 2024
Main results expectedMay 27, 2026
Study endsApril 30, 2027
Registry record updatedSeptember 24, 2025
Trial IDNCT06672250 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include adults aged 18 and older with a history of cancer or those who have been cancer-free for at least five years and have undergone catheter-based thrombectomy.

Probably not a fit

Patients experiencing shock or severe sepsis, or those with a recent cancer diagnosis within the last five years, may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study investigates the relationship between circulating tumor cells and venous thrombosis in cancer patients. It aims to compare leukocyte populations in cancer-associated thrombosis and venous thromboembolism, identify factors contributing to increased thrombosis risk, and evaluate the effects of aspirin or NOACs on these conditions. The study will analyze circulating tumor cells from biopsies to better understand cancer metastasis and its implications for thrombosis. By examining these factors, the research seeks to enhance the understanding of cancer-related thrombosis mechanisms.

Why it matters

Potential benefit: If successful, this study could lead to improved prevention and treatment strategies for venous thrombosis in cancer patients.

How similar studies have gone: Other studies have indicated a strong correlation between cancer and thrombosis, suggesting that this approach is supported by existing research.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. age≧18
2. participants (1)participants without cancer: without cancer in five years (2)participants with cancer:pathology reveal have malignant tumor
3. patients who underwent catheter-based thrombectomy
4. agree do the thrombectomy

Exclusion Criteria:

1. participants without cancer (1).shock (2).severe sepsis (3).with cancer in five years
2. participants with cancer (1).shock (2).severe sepsis

Where it's running

  • New Taipei City TuCheng Hospital
    New Taipei City, Taiwan
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.